First Horizon Pharmaceutical Quote - FHRX

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

Bid

Ask

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Previous Close

Open

Last Trade

Last Trade Time

Average Volume (3m)

Financial Volume

VWAP

What were the results of the latest earnings call for First Horizon Pharmaceutical (MM) (FHRX)?
What are the analysts ratings and price targets for First Horizon Pharmaceutical (MM) (FHRX)?
Compare First Horizon Pharmaceutical (MM) (FHRX) to its industry peers.
What is First Horizon Pharmaceutical (MM) (FHRX) core business model and revenue streams?
Who are the top holders of First Horizon Pharmaceutical (MM) (FHRX) stock?

First Horizon Pharmaceutical Corporation Stockholders Approve Name Change to Sciele Pharma, Inc.

Stockholders of First Horizon Pharmaceutical Corporation (NASDAQ:FHRX), voting today at the Company's 2006 Annual Meeting, approved the Company's name change to Sciele Pharma, Inc. The Company's...

First Horizon Receives FDA Orphan Drug Designation for Its Glycopyrrolate to Treat Chronic Drooling in Pediatric Patients

First Horizon Pharmaceutical Corporation (NASDAQ:FHRX) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the Company's glycopyrrolate, which...

SkyePharma to Develop Improved Controlled Release Version of Sular for First Horizon

LONDON, May 22 /PRNewswire-FirstCall/ -- SkyePharma PLC (NASDAQ:SKYE) ( LSE: SKP) announces that it has entered into an agreement with First Horizon Pharmaceutical Corporation ("First Horizon...

First Horizon Pharmaceutical Corporation

First Horizon Pharmaceutical Corporation (NASDAQ: FHRX), a specialty pharmaceutical company, today announced that the chairman of its Board of Directors, Dr. John N. Kapoor, through an...

First Horizon Pharmaceutical Corporation Increases Adjusted Diluted Earnings Per Share (EPS) Guidance by $0.10 to $1.27-$1.32 f

First Horizon Pharmaceutical Corporation (NASDAQ:FHRX) today announced that the Company has increased its adjusted diluted earnings per share (a non-GAAP measure) guidance by $0.10 to $1.27...

First Horizon Pharmaceutical Corporation Announces Expiration of and Successful 100% Participation in Its Exchange Offer for It

Exchange Offer Reduced Number of Fully Diluted Shares by Approximately 6,772,000 ? First Horizon Pharmaceutical Corporation (Nasdaq:FHRX), a specialty pharmaceutical company, today announced...

First Horizon to Present at Deutsche Bank Securities 31st Annual Health Care Conference

First Horizon Pharmaceutical Corporation (Nasdaq:FHRX), a specialty pharmaceutical company, today announced that Patrick Fourteau, President and Chief Executive Officer, will make a presentation...

First Horizon Pharmaceutical Reports Revenue and EPS Growth for the First Quarter 2006

First Horizon Pharmaceutical Corporation (NASDAQ:FHRX): ? First Quarter 2006 Results Include: ? -- Revenues increased 62% to $66.5 million compared with $41.0 million in the first quarter of...

First Horizon Pharmaceutical Corporation Announces Extension and Modification of Its Exchange Offer for Its Outstanding 1.75% C

First Horizon Pharmaceutical Corporation (Nasdaq:FHRX), a specialty pharmaceutical company, today announced that it is extending its exchange offer in which it is offering to exchange New 1.75...

First Horizon Announces First-Quarter 2006 Earnings Release Date and Conference Call

First Horizon Pharmaceutical Corporation (NASDAQ:FHRX), a specialty pharmaceutical company, will release financial results for the first quarter ended March 31, 2006, after the market closes...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

FHRX - Frequently Asked Questions (FAQ)

What is the current First Horizon Pharmaceutical share price?

The current share price of First Horizon Pharmaceutical is US$ 0.00

What is the 1 year trading range for First Horizon Pharmaceutical share price?

First Horizon Pharmaceutical has traded in the range of US$ 0.00 to US$ 0.00 during the past year

Symbol	Price	Vol.
MYSZMy Size Inc	US$ 4.2001 (211.12%)	120.01M
NVNINVNI Group Ltd	US$ 8.26 (209.36%)	76.64M
TPICTPI Composites Inc	US$ 2.45 (100.82%)	33.95M
ICGIntchains Group Ltd	US$ 8.77 (88.60%)	527.61k
HSDTHelius Medical Technologies Inc	US$ 0.884851 (84.34%)	120.4M
CYNCYNGN Inc	US$ 0.4603 (-71.41%)	27.91M
MTEMMolecular Templates Inc	US$ 0.1502 (-57.09%)	8.75M
PRFXPainReform Ltd	US$ 5.15 (-53.85%)	2.94M
GALTGalectin Therapeutics Inc	US$ 1.03 (-48.50%)	9.27M
BCABBioAtla Inc	US$ 0.6923 (-41.82%)	6.25M
EDBLEdible Garden AG Inc	US$ 0.24 (65.06%)	354.33M
NVDANVIDIA Corporation	US$ 134.70 (3.08%)	310.19M
APTOAptose Biosciences Inc	US$ 0.28 (64.51%)	306.25M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.606999 (6.49%)	293.22M
PLTRPalantir Technologies Inc	US$ 80.55 (8.54%)	281.23M

Symbol

Price

Vol.

EDBLEdible Garden AG Inc

US$ 0.24

(65.06%)

354.33M

NVDANVIDIA Corporation

US$ 134.70

(3.08%)

310.19M

APTOAptose Biosciences Inc

US$ 0.28

(64.51%)

306.25M

TNXPTonix Pharmaceuticals Holding Corporation

US$ 0.606999

(6.49%)

293.22M

PLTRPalantir Technologies Inc

US$ 80.55

(8.54%)

281.23M

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

First Horizon Pharmaceutical (MM) (FHRX)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Ask ADVFN Intelligence (AI)

FHRX Latest News

First Horizon Pharmaceutical Corporation Stockholders Approve Name Change to Sciele Pharma, Inc.

First Horizon Receives FDA Orphan Drug Designation for Its Glycopyrrolate to Treat Chronic Drooling in Pediatric Patients

SkyePharma to Develop Improved Controlled Release Version of Sular for First Horizon

First Horizon Pharmaceutical Corporation

First Horizon Pharmaceutical Corporation Increases Adjusted Diluted Earnings Per Share (EPS) Guidance by $0.10 to $1.27-$1.32 f

First Horizon Pharmaceutical Corporation Announces Expiration of and Successful 100% Participation in Its Exchange Offer for It

First Horizon to Present at Deutsche Bank Securities 31st Annual Health Care Conference

First Horizon Pharmaceutical Reports Revenue and EPS Growth for the First Quarter 2006

First Horizon Pharmaceutical Corporation Announces Extension and Modification of Its Exchange Offer for Its Outstanding 1.75% C

First Horizon Announces First-Quarter 2006 Earnings Release Date and Conference Call

FHRX - Frequently Asked Questions (FAQ)

Movers

Discussion

Your Recent History

Company

Business

Popular

Get The App

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

First Horizon Pharmaceutical (MM) (FHRX) Share Price

First Horizon Pharmaceutical (MM) (FHRX)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Ask ADVFN Intelligence (AI)

FHRX Latest News

FHRX - Frequently Asked Questions (FAQ)

Movers

Discussion

Your Recent History

Company

Business

Popular

Get The App

Go Ad-Free

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS